FindTrial
Sign In

EFFECT OF SHATAPUSHPA CHURNA IN DECREASED ANTI MULLERIAN HORMONE LEVEL

EFFECT OF SHATAPUSHPA CHURNA IN POOR OVARIAN RESERVE W.S.R. ANTI MULLERIAN HORMONE -AN OPEN CLINICAL TRIAL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/11/028780
Enrollment
10
Registered
2020-11-02
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: R00-R99- Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

Interventions

Intervention1: Shatapushpa Churna: Daily administration of Shatapushpa churna for a period of 90 days Dose : 6gms BD Control Intervention1: N/A: N/A

Sponsors

Shri B M K Ayurveda Mahavidyalaya shahapur belagavi
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Clinically diagnosed cases of: • Regular/ irregular menstrual history • Laboratory diagnosed case of: • Low AMH • Normal BMI (18.5 â?? 24.9)

Exclusion criteria

Exclusion criteria: • Known case of PCOS • Ovarian cyst • Recent history of exposure to cytotoxic drugs or pelvic radiation therapy. • K/C/O Sexually transmitted diseases. • Subjects with known cases of congenital anomalies and carcinoma of reproductive tract. • Patients with other major systematic disorders which interfere with the treatment.

Design outcomes

Primary

MeasureTime frame
Shatapushpa churna may be effective in increasing the AMH levels in poor ovarian reserveTimepoint: At the end of the study—

Secondary

MeasureTime frame
ConceptionTimepoint: At the end of the study—

Countries

India

Contacts

Public ContactDr Anita Dandappanavar

KAHERS Shri BMK Ayurveda Mahavidyalaya Shahapur Belagavi

uppinswarda@gmail.com9972271893

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026